Tempus Announces Dr. Ned Sharpless as a Senior Strategic Advisor
Tempus, a leader in artificial intelligence and precision medicine, today announced that Norman E. “Ned” Sharpless, MD, will serve as a senior strategic advisor to Tempus and its leadership team, leveraging his vast experience as a medical policy expert and cancer researcher to further the company’s mission of improving patient outcomes.
- Tempus, a leader in artificial intelligence and precision medicine, today announced that Norman E. “Ned” Sharpless, MD, will serve as a senior strategic advisor to Tempus and its leadership team, leveraging his vast experience as a medical policy expert and cancer researcher to further the company’s mission of improving patient outcomes.
- Dr. Sharpless was most recently the Director of the National Cancer Institute (NCI), part of the National Institutes of Health, a position he held from 2017 to 2022.
- At the NCI, Dr. Sharpless was instrumental in championing health equity and modernizing clinical trials, among many other accomplishments.
- Sharpless has had an indelible impact on the medical community in addressing major public health challenges and spurring innovation,” said Eric Lefkofsky, Founder and CEO of Tempus.